TuHURA Biosciences, Inc.
HURA
$4.10
-$0.13-3.07%
NASDAQ
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 119.31% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 52.67% | ||||
| Operating Income | -52.67% | ||||
| Income Before Tax | -7.47% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -7.47% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -7.47% | ||||
| EBIT | -52.67% | ||||
| EBITDA | -53.55% | ||||
| EPS Basic | -65.34% | ||||
| Normalized Basic EPS | -93.65% | ||||
| EPS Diluted | -65.34% | ||||
| Normalized Diluted EPS | -93.65% | ||||
| Average Basic Shares Outstanding | -44.58% | ||||
| Average Diluted Shares Outstanding | -44.58% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||